Use of [18F]Fluoro-2-deoxy-D-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial

Chest

Volumn 150, Issue 3, 2016, Pages 621-630

  Nair, Viswam S ^a   Sundaram, Vandana ^a   Gould, Michael K ^b   Desai, Manisha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

lung cancer; National Lung Screening Trial; positron emission tomography; screening; 18F Fluoro 2 deoxy D glucose positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; GENDER; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYCOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; RADIOLOGIST; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG; LUNG TUMOR; MORTALITY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84995642746     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.05.006     Document Type: Article

References (28)

1. 1 Gambhir, S.S., Shepherd, J.E., Shah, B.D., et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 16:6 (1998), 2113–2125.
2. 2 Gould, M.K., Maclean, C.C., Kuschner, W.G., Rydzak, C.E., Owens, D.K., Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:7 (2001), 914–924.
3. 3 Gould, M.K., Sanders, G.D., Barnett, P.G., et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 138:9 (2003), 724–735.
4. 4 van Tinteren, H., Hoekstra, O.S., Smit, E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:9315 (2002), 1388–1393.
5. 5 National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:5 (2011), 395–409.
6. 6 Humphrey, L.L., Helfand, M., Chan, B.K., Woolf, S.H., Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:5 Part 1 (2002), 347–360.
7. 7 Ferlitsch, M., Reinhart, K., Pramhas, S., et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 306:12 (2011), 1352–1358.
8. 8 Black, W.C., Gareen, I.F., Soneji, S.S., et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371:19 (2014), 1793–1802.
9. 9 de Koning, H.J., Meza, R., Plevritis, S.K., et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160:5 (2014), 311–320.
10. 10 Gould, M.K., Donington, J., Lynch, W.R., et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:5 Suppl (2013), e93S–e120S.
11. 11 Ettinger, D.S., Akerley, W., Borghaei, H., et al. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw 11:6 (2013), 645–653.
12. 12 Wahidi, M.M., Govert, J.A., Goudar, R.K., Gould, M.K., McCrory, D.C., Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:3 Suppl (2007), 94S–107S.
13. 13 Buck, A.K., Herrmann, K., Stargardt, T., Dechow, T., Krause, B.J., Schreyogg, J., Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J Nucl Med 51:3 (2010), 401–412.
14. 14 Ashraf, H., Dirksen, A., Loft, A., et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning. Thorax 66:4 (2011), 315–319.
15. 15 Bastarrika, G., Garcia-Velloso, M.J., Lozano, M.D., et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 171:12 (2005), 1378–1383.
16. 16 Pastorino, U., Bellomi, M., Landoni, C., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362:9384 (2003), 593–597.
17. 17 National Lung Screening Trial Research Team, Aberle, D.R., Berg, C.D., et al. The National Lung Screening Trial: overview and study design. Radiology 258:1 (2011), 243–253.
18. 18 Rahmim, A., Qi, J., Sossi, V., Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls. Med Phys, 40(6), 2013, 064301.
19. 19 Deppen, S.A., Blume, J.D., Kensinger, C.D., et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. JAMA 312:12 (2014), 1227–1236.
20. 20 Tanner, N.T., Aggarwal, J., Gould, M.K., et al. Management of pulmonary nodules by community pulmonologists: a multicenter observational study. Chest 148:6 (2015), 1405–1414.
21. 21 Wiener, R.S., Gould, M.K., Slatore, C.G., Fincke, B.G., Schwartz, L.M., Woloshin, S., Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med 174:6 (2014), 871–880.
22. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47:6 (2006), 1059–1066.
23. 23 Humphrey, L., Deffebach, M., Pappas, M., et al. Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. [Evidence Synthesis No. 105], 2013, Agency for Healthcare Research and Quality, Rockville, MD AHRQ publication 13-05188-EF-1 http://www.ncbi.nlm.nih.gov/books/NBK154610/pdf/Bookshelf_NBK154610.pdf Published July 2013. Accessed June 15, 2016.
24. 24 Cao, J.Q., Rodrigues, G.B., Louie, A.V., Zaric, G.S., Systematic review of the cost-effectiveness of positron-emission tomography in staging of non–small-cell lung cancer and management of solitary pulmonary nodules. Clin Lung Cancer 13:3 (2012), 161–170.
25. 25 Ioannidis, J.P., Why most published research findings are false. PLoS Med, 2(8), 2005, e124.
26. 26 Ost, D., Fein, A.M., Feinsilver, S.H., Clinical practice: the solitary pulmonary nodule. N Engl J Med 348:25 (2003), 2535–2542.
27. 27 Tan, B.B., Flaherty, K.R., Kazerooni, E.A., Iannettoni, M.D., American College of Chest Physicians. The solitary pulmonary nodule. Chest 123:1 Suppl (2003), 89S–96S.
28. 28 Fischer, B., Lassen, U., Mortensen, J., et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:1 (2009), 32–39.